Cancer Research UK have announced a new trial that could revolutionise how children with neuroblastoma are diagnosed.
Cancer Research UK is to increase investment by nearly 50 per cent over the next five years in its Centre for Drug Development.
It may seem as though we’re constantly asked to give feedback – but what’s more important is knowing what’s happened as a result of our comments – have we...
Cancer Research UK and Medimmune establish joint CRUK-Medi alliance laboratory to develop new biologic cancer medicines
Cancer Research Technology (CRT) has announced a collaboration with AstraZeneca and MedImmune to establish a joint laboratory in Cambridge.
Immune cells may be responsible for drug resistance in melanoma patients, according to research published in Cancer Discovery.